Fragment screening of infectious disease targets in a structural genomics environment
- PMID: 21371605
- PMCID: PMC4472360
- DOI: 10.1016/B978-0-12-381274-2.00021-2
Fragment screening of infectious disease targets in a structural genomics environment
Abstract
Structural genomics efforts have traditionally focused on generating single protein structures of unique and diverse targets. However, a lone structure for a given target is often insufficient to firmly assign function or to drive drug discovery. As part of the Seattle Structural Genomics Center for Infectious Disease (SSGCID), we seek to expand the focus of structural genomics by elucidating ensembles of structures that examine small molecule-protein interactions for selected infectious disease targets. In this chapter, we discuss two applications for small molecule libraries in structural genomics: unbiased fragment screening, to provide inspiration for lead development, and targeted, knowledge-based screening, to confirm or correct the functional annotation of a given gene product. This shift in emphasis results in a structural genomics effort that is more engaged with the infectious disease research community, and one that produces structures of greater utility to researchers interested in both protein function and inhibitor development. We also describe specific methods for conducting high-throughput fragment screening in a structural genomics context by X-ray crystallography.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei.J Struct Funct Genomics. 2011 Jul;12(2):63-76. doi: 10.1007/s10969-011-9102-6. Epub 2011 Feb 26. J Struct Funct Genomics. 2011. PMID: 21359640 Free PMC article.
-
Predicting the success of fragment screening by X-ray crystallography.Methods Enzymol. 2011;493:91-114. doi: 10.1016/B978-0-12-381274-2.00004-2. Methods Enzymol. 2011. PMID: 21371588
-
The Seattle Structural Genomics Center for Infectious Disease (SSGCID).Infect Disord Drug Targets. 2009 Nov;9(5):493-506. doi: 10.2174/187152609789105687. Infect Disord Drug Targets. 2009. PMID: 19594426 Free PMC article. Review.
-
The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.Essays Biochem. 2017 Nov 8;61(5):495-503. doi: 10.1042/EBC20170051. Print 2017 Nov 8. Essays Biochem. 2017. PMID: 29118096 Free PMC article. Review.
-
Structural genomics approach to drug discovery for Mycobacterium tuberculosis.Curr Opin Microbiol. 2009 Jun;12(3):318-25. doi: 10.1016/j.mib.2009.04.006. Epub 2009 May 28. Curr Opin Microbiol. 2009. PMID: 19481971 Review.
Cited by
-
Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba.PLoS One. 2021 Mar 24;16(3):e0241738. doi: 10.1371/journal.pone.0241738. eCollection 2021. PLoS One. 2021. PMID: 33760815 Free PMC article.
-
Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei.J Struct Funct Genomics. 2011 Jul;12(2):63-76. doi: 10.1007/s10969-011-9102-6. Epub 2011 Feb 26. J Struct Funct Genomics. 2011. PMID: 21359640 Free PMC article.
-
Probing conformational states of glutaryl-CoA dehydrogenase by fragment screening.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Sep 1;67(Pt 9):1060-9. doi: 10.1107/S1744309111014436. Epub 2011 Aug 13. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011. PMID: 21904051 Free PMC article.
-
Recent contributions of structure-based drug design to the development of antibacterial compounds.Curr Opin Microbiol. 2015 Oct;27:133-8. doi: 10.1016/j.mib.2015.09.003. Curr Opin Microbiol. 2015. PMID: 26458180 Free PMC article. Review.
-
Structural genomics of infectious disease drug targets: the SSGCID.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Sep 1;67(Pt 9):979-84. doi: 10.1107/S1744309111029204. Epub 2011 Aug 13. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011. PMID: 21904037 Free PMC article.
References
-
- Abad-Zapatero C, Metz JT. Ligand efficiency indices as guideposts for drug discovery. Drug Discov Today. 2005;10:464–469. - PubMed
-
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. - PubMed
-
- Andrews PR, Craik DJ, Martin JL. Functional group contributions to drug-receptor interactions. J Med Chem. 1984;27:1648–1657. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials